Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
50%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (50.0%)
N/A2 (50.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Assessing the Efficacy of Different Carrier Systems in Oral Vitamin B12 Supplementation

NCT06376591
completednot_applicable

A Comparison of Two Different Doses of Maternal B12 Supplementation in Improving Infant B12 Deficiency and Neurodevelopment

NCT04083560
unknownphase_2

The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

NCT04425590
completedphase_2

Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults

NCT00480207

Clinical Trials (4)

Showing 4 of 4 trials
NCT06376591Not Applicable

Assessing the Efficacy of Different Carrier Systems in Oral Vitamin B12 Supplementation

Completed
NCT04083560Not Applicable

A Comparison of Two Different Doses of Maternal B12 Supplementation in Improving Infant B12 Deficiency and Neurodevelopment

Completed
NCT04425590Phase 2

The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

Unknown
NCT00480207Phase 2

Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4